Cargando…
S-11-02 Regulatory considerations for non-clinical studies for COVID-19 vaccines: US FDA perspective
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465511/ http://dx.doi.org/10.1016/j.toxlet.2022.07.101 |
| _version_ | 1784787814795182080 |
|---|---|
| author | Wrzesinski, C. |
| author_facet | Wrzesinski, C. |
| author_sort | Wrzesinski, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9465511 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94655112022-09-12 S-11-02 Regulatory considerations for non-clinical studies for COVID-19 vaccines: US FDA perspective Wrzesinski, C. Toxicol Lett Scientific Sessions Elsevier B.V. 2022-09-01 2022-09-12 /pmc/articles/PMC9465511/ http://dx.doi.org/10.1016/j.toxlet.2022.07.101 Text en Copyright © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Scientific Sessions Wrzesinski, C. S-11-02 Regulatory considerations for non-clinical studies for COVID-19 vaccines: US FDA perspective |
| title | S-11-02 Regulatory considerations for non-clinical studies for COVID-19 vaccines: US FDA perspective |
| title_full | S-11-02 Regulatory considerations for non-clinical studies for COVID-19 vaccines: US FDA perspective |
| title_fullStr | S-11-02 Regulatory considerations for non-clinical studies for COVID-19 vaccines: US FDA perspective |
| title_full_unstemmed | S-11-02 Regulatory considerations for non-clinical studies for COVID-19 vaccines: US FDA perspective |
| title_short | S-11-02 Regulatory considerations for non-clinical studies for COVID-19 vaccines: US FDA perspective |
| title_sort | s-11-02 regulatory considerations for non-clinical studies for covid-19 vaccines: us fda perspective |
| topic | Scientific Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465511/ http://dx.doi.org/10.1016/j.toxlet.2022.07.101 |
| work_keys_str_mv | AT wrzesinskic s1102regulatoryconsiderationsfornonclinicalstudiesforcovid19vaccinesusfdaperspective |